Since CML disease progression correlates with high CIP2A levels,5, 29 as well as changes in expression levels of different BCL-2 family members (Figure 3), we speculated whether CIP2A levels could correlate with the expression levels of different BCL-2 family members. The gene discussed is BCL2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.